The increased expression of Nrf-2 in glioblastoma was found to protect glioma cells from the killing effects of antitumor therapies, and the blocking of Nrf-2 and related key molecules such as GSH can inhibit glioma cells [24,25,26]. This evidence concerns the gene NFE2L2 and central nervous system cancer.